SUMMARY. The effects of acute hypoxemia and hypercapnic acidosis were examined in five unanesthetized dogs in which sodium intake was controlled at 80 mEq/24 hours for 4 days prior to study. Each animal was studied during combined acute hypoxemia and hypercapnic acidosis (Pac>2 = 36 ± 1 mm Hg, Paco? = 52 ± 1 mm Hg, pH = 7.18 ± 0.02), acute hypoxemia alone (Pac>2 = 32 ± 1 mm Hg, Pacch = 32 ± 1 mm Hg, pH = 7.34 ± 0.01), and acute hypercapnic acidosis alone (Paoj = 82 ± 2 mm Hg, Paco? = 51 ± 1 mm Hg, pH = 7.18 ± 0.02). Although mean arterial pressure, cardiac output, and heart rate increased during combined hypoxemia and hypercapnic acidosis, effective renal plasma flow and glomerular filtration rate decreased. In addition, filtered sodium load and urinary sodium excretion decreased during combined hypoxemia and hypercapnic acidosis. Either acute hypoxemia or hypercapnic acidosis alone resulted in increased mean arterial pressure, cardiac output, and heart rate. However, in contrast to their combined effects, renal hemodynamic function was unchanged and natriuresis was observed. Measurement of plasma renin activity and angiotensin II concentrations indicated that hypoxemia or hypercapnic acidosis alone resulted in moderate activation of the renin-angiotensin system. Moreover, combined hypoxemia and hypercapnic acidosis acted synergistically resulting in major renin-angiotensin activation. Systemic angiotensin II blockade using 1-sarcosine, 8-alanine, angiotensin II (2 Mg/kg per min) during combined acute hypoxemia and hypercapnic acidosis resulted in decreased renal hemodynamic function. We conclude that acute hypoxemia and hypercapnic acidosis act synergistically to increase mean arterial pressure, diminish renal hemodynamic function and activate the renin-angiotensin system. Systemic angiotensin inhibition studies suggest activation of the renin-angiotensin system maintains renal hemodynamic function during combined hypoxemia and hypercapnic acidosis, instead of mediating the renal vasoconsrriction. (Circ Res 53: 202-213, 1983) 
PATIENTS with respiratory failure frequently develop diminished renal function, including diminished renal plasma flow (Aber et al., 1963; Farber et al., 1977) , diminished glomerular filtration rate (Daggett, 1977) , diminished urinary sodium excretion (Kilburn and Dowell, 1971) , and diminished free water excretion (White and Woodings, 1971) . Although blood gas derangements are invariably present, their role in these renal abnormalities has remained unclear.
In patients with respiratory failure, a correlation has been noted between hypoxemia/hypercapnia and renal dysfunction and edema. In 1960, Campbell and Short noted that the onset of CO 2 retention heralded the appearance of edema in patients with chronic obstructive lung disease (Campbell and Short, 1960) . Moreover, the combination of hypoxemia and hypercapnia in patients was correlated with diminished renal plasma flow (Aber et al., 1963; Farber et al., 1977) and increased plasma renin activity (Farber et al., 1977) . However, interpretation of these clinical studies was difficult because of the presence of heart failure, chronic obstructive lung disease, and multiple medications.
Previous laboratory investigations have provided little insight into the role of blood gas derangements in abnormalities of renal function observed in clinical studies. Previous studies which have documented diminished renal function during acute hypoxemia or hypercapnic acidosis were performed in anesthetized, mechanically ventilated animals. To date, induction of moderate acute hypoxemia (Axelrod and Pitts, 1952; Ullman, 1961; Tuffley et al., 1970; Liang and Gavras, 1978) or acute hypercapnic acidosis (Barbour et al., 1953; Anderson et al., 1980; Rose et al., 1982) in healthy human subjects or unanesthetized laboratory animals has been unassociated with impairment of renal function, despite activation of the renin-angiotensin system (Liang and Gavras, 1978; Anderson et al., 1980) . The effects of combined hypoxemia and hypercapnic acidosis on renal and cardiovascular function are poorly understood. Recently, combined acute hypoxemia and hypercapnic acidosis resulted in diminished renal blood flow in conscious dogs (Koehler et al., 1980) . However, the impact on other aspects of renal function was not investigated. Thus, the physiological importance of blood gas derangements with regard to renal function has remained unclear.
To elucidate the effects of blood gas derangements on renal function, a study systematically evaluating the effects of single and combined blood gas derangements on renal function in unanesthetized animals is requisite. Therefore, the present investigation was undertaken to determine the effects of acute hypoxemia and hypercapnic acidosis separately and together on systemic and renal hemodynamic function, renal sodium excretion, and the renin-angiotensin system in unanesthetized animals in careful sodium balance.
Methods

Animal Preparation
Studies were performed on five unanesthetized female mongrel dogs weighing 19.4-27.4 kg. Surgical procedures performed at least 4 weeks prior to study, using pentobarbital anesthesia (30 mg/kg, iv) included: (1) exteriorization of the left carotid artery into a carotid loop for measurement of arterial pressure and sampling of arterial blood, (2) tracheostomy for monitoring and control of oxygen and carbon dioxide levels in respirable gas, and (3) splenectomy. Previous investigators have observed an increase in hematocrit during acute hypercapnic acidosis in unsplenectomized anesthetized dogs (Berns et al., 1979) . Therefore, each animal was splenectomized to prevent possible increase in hematocrit or total blood volume during the acute blood gas derangements. Animals were excluded from study in the event of fever, infection at a surgical site, or inability to exercise normally.
Sodium balance was established with a palatable diet containing 5 mEq sodium/24 hours (Hill's Prescription Diet h/d) and daily administration of 500 ml of 0.9% NaCl (75 mEq of sodium) by intravenous infusion given over 30 minutes. Constant sodium intake was maintained for 4 days prior to study, and a 24-hour urine collection was obtained from a stainless steel metabolic cage just before study to confirm the state of sodium balance. Before study, each animal was allowed free access to water, but food was withheld for approximately 18 hours.
Catheters inserted on the morning of study included an 18F bladder catheter (Travenol), percutaneous 18-gauge carotid loop catheter (Becton-Dickinson), and a central venous catheter (PE 160, Clay Adams) via percutaneous route through the right external jugular vein. Percutaneous catheters were inserted painlessly by prior intradermal lidocaine anesthesia. A tracheostomy tube (Portex 9.7 mm id) was inserted and secured, and the cuff was inflated in order to divert all respirable gas through the tube. After preparation, each animal was positioned for the study in a Pavlovian sling, and an infusion of D 5 W was begun at 0.5 ml/min containing concentrations of inulin and paminohippurate to establish and maintain blood levels between 15 and 20 mg/dl and 1-3 mg/dl, respectively. The tracheostomy tube was attached through a two-way Rudolph valve by corrugated plastic tubing so that ambient room air passed through the mixing chamber to the animal during inhalation. Exhaled gas exited through the Rudolph valve into the room.
Protocols (Table 1)
Effects of Acute Hypoxemia and Hypercapnic Acidosis in Intact Conscious Animals
The protocols were begun after 1 hour of equilibration in the sling, and after documentation of stable urine flow. The sequence of each protocol is outlined in Table 1 . Measurements were obtained during four consecutive 20-minute control periods (C). Subsequently, the effects of acute hypoxemia alone or acute hypercapnia alone were determined during four consecutive 20-minute periods during the first blood gas derangement (BGD,). This was followed by determination of the effects of combined acute hypoxemia and hypercapnia for two 20-minute periods during the second blood gas derangement (BGD 2 ). Post-control measurements were obtained during a 20-minute period, 40 minutes after cessation of the combined blood gas derangement. Each dog was studied on separate days in five protocols performed in random order at least 2 weeks apart.
Protocol I: Combined Acute Hypoxemia and Hypercapnia
Preceded by Acute Hypoxemia. Following control measurements, acute hypoxemia (HYPOX) was induced in the first blood gas derangement period, followed by combined acute hypoxemia and hypercapnia (HYPOX + HC) in the second period.
Protocol II: Combined Acute Hypoxemia and Hypercapnia
Preceded by Acute Hypercapnic Acidosis. The protocol was altered such that acute hypercapnic acidosis (HC) was induced during the first blood gas derangement period, followed by the combined derangement (HC + HYPOX).
Protocol III: Acute Hypoxemia Alone. Acute hypoxemia (HYPOX] ) was continued into the second blood gas derangement period (HYPOX 2 ) corresponding to the combined period in Protocol I. This allowed assessment of whether effects observed during the combined derangement were due to actual combination or increased duration of hypoxemia.
Protocol IV: Acute Hypercapnic Acidosis Alone. Acute hypercapnic acidosis (HCi) was continued into the second blood gas derangement period (HC 2 ) corresponding to the combined period in Protocol II. This allowed assessment of effects of continuing hypercapnic acidosis compared to combined blood gas derangement.
Protocol V: Normoxemic, Normocapnic Time-Control. Effects of the protocol including infusions, drugs, and stress were controlled by precisely repeating the study in the absence of blood gas abnormalities on a separate day. In order to assess the role of the renin-angiotensin system in the systemic and renal responses observed during combined acute hypoxemia and hypercapnic acidosis, each animal was studied in three additional protocols. Measurements were obtained during two consecutive 20-minute control periods (C), two consecutive 20-minute periods of combined acute hypoxemia and hypercapnic acidosis (combined HYPOX and HC) and two 20-minute post-control periods (PC) 40 minutes after cessation of combined HYPOX and HC (Table 1) . Each dog was studied on separate days in three protocols performed at least 2 weeks apart. (Johnson and Davis, 1973; Carey et al., 1978) . To control for this potential action, Protocol VII was repeated with [Sa^Ala^-AII infusion in D 5 W at 2 Mg/kg per min in four dogs, except that the animals breathed room air throughout the entire protocol, and the vasopressin inhibitor vehicle was not administered The systemic pressor response to 1000 ng of intravenous angiotensin I was reduced to -51 ± 29% of the response in Protocol VI.
Effects of Combined
Induction of Blood Gas Derangements
Acute hypoxemia was induced by adding 100% N 2 to the inspired air via the mixing chamber until the end-tidal oxygen fraction (FEOJ) , measured by a fuel cell oxygen analyzer (Applied Technical Products), fell to 0.07. During the ensuing hyperpnea, hypocapnia was prevented by adding sufficient CO 2 to the inspired air to maintain the end-tidal CO 2 fraction (FECO,), measured by an infrared CO 2 analyzer (Beckman LB-2), at the control level.
Acute hypercapnic acidosis was induced by adding 100% CO 2 to the inspired air until the FECO, was 0.085. During the resulting hyperpnea, small amounts of 100% N 2 were added to maintain the FEO 2 at the control level, thus preventing hyperoxemia.
Combined acute hypoxemia and hypercapnia were induced by separately adding 100% N 2 and CO 2 to the inspired air (mixing chamber) until the FEO, and FECO, were 0.07 and 0.085, respectively.
Hemodynamic Measurements and Assays
Arterial pressure was measured from the carotid loop using a vascular transducer (Hewlett-Packard) zeroed 5 cm dorsal to the sternum in the upright animal. Cardiac output was obtained by central venous injection of indocyanine green dye with sampling of arterial blood through a cuvette densitometer (Gilford 103IR). Total peripheral resistance was calculated by dividing the mean arterial pressure by the cardiac output.
Blood samples were obtained at the mid-point of each 20-minute urine collection period. Plasma and urine sodium and potassium were measured by flame photometry (Instrumentation Laboratory 143) using lithium as an internal standard. Plasma and urine osmolality were measured by freezing point depression (Fiske OS Osmometer). Plasma and urine inulin (Heyrovsky, 1956 ) and p-aminohippurate (Brun, 1951) were measured by spectrophotometry, and renal clearances were used to estimate glomerular filtration rate and effective renal plasma flow, respectively. We have previously observed that renal p-aminohippurate extraction was unchanged in anesthetized animals during acute hypercapnic acidosis (Anderson et al., 1980) . Although p-aminohippurate extraction was not measured during combined hypoxemia and hypercapnic acidosis, the parallel decrease in glomerular filtration rate and urinary sodium excretion indicated that changes in extraction were unlikely.
Specimens for plasma renin activity and angiotensin II assays were collected in EDTA, centrifuged at 4°C, and stored at -80°C. Plasma renin activity was measured by a radioimmunoassay technique (Sealey and Laragh, 1979) . Plasma angiotensin II concentrations were measured by a modification of a previously described radioimmunoassay technique (Freedlender and Goodfriend, 1979) . The sample volume was increased by 70% with a water-washed slurry of AG 50W-X2, hydrogen form (Bio-Rad Laboratories) instead of Fuller's Earth and mixed for 60 minutes on a rotator (20 rpm) at 4°C. This assay measured [desAsp']-angiotensin II (angiotensin III), as well as angiotensin II.
Arterial blood gases were collected anaerobically and analyzed within 30 minutes (BMS3, Radiometer). Hematocrit was measured by the microhematocrit method (IEC MB).
Data Analysis
Data were analyzed by 1-and 2-way analysis of variance (Steele and Torrie, 1960) . Effects of blood gas derangements were determined by comparison of blood gas derangement periods to each other, and to the respective control (protocol control) and post-control (protocol postcontrol) periods for each protocol on the same day. In addition, blood gas derangement periods were compared to comparable periods performed on different days. Multiple comparisons were performed using Duncan's multiple range test (Steele and Tome, 1960) . Unless noted, it can be considered that group comparisons were insignificant (P > 0.05). In the text, all tables, and figures, variables are expressed as the mean ± SE.
Results
Alterations in Arterial Blood Gases (Table 2) Induction of acute blood gas derangements in the conscious dogs resulted in moderate acute hypoxemia and hypercapnic acidosis concomitant with increased minute ventilation ( Table 2) . Although arterial pH during HYPOX + HC suggests an element of metabolic acidosis, calculated bicarbonate was unchanged. Moreover, arterial pH was comparable (P = NS) during HYPOX + HC, compared with HC + HYPOX periods in Protocols I and II. 3 and 4, Figs. 1-3) Mean arterial pressure ( Fig. 1 ) was increased (P < 0.0005) during HYPOX + HC and HC + HYPOX, compared with the protocol control. Mean arterial pressure increased further (P < 0.005) from the single blood gas derangement during HYPOX + HC and HC + HYPOX in Protocols I and II, respectively. By way of contrast, mean arterial pressure was unchanged from HYPOX, to HYPOX 2 and from HC, to HC 2 during HYPOX alone and HC alone, respectively. Comparison of responses in the second blood gas derangement period revealed that HC + HYPOX resulted in increased (P < 0.05) mean arterial pressure, compared with HC 2 , but mean arterial pressure was unchanged during HYPOX + HC, compared with HYPOX 2 . Heart rate and cardiac output (Table  3 ) increased (P < 0.05) during both combined HY-POX + HC and HC + HYPOX. However, heart rate fell (P < 0.001) from HYPOX to HYPOX + HC. Total peripheral resistance (Table 3) was diminished (P < 0.05) during HYPOX + HC, compared with protocol control in Protocol I.
Systemic Hemodynamic and Renal Effects of Combined Acute Hypoxemia and Hypercapnic Acidosis (Tables
Glomerular filtration rate (Fig. 2 ) and effective renal plasma flow (Fig. 3 ) fell (P < 0.005) during HYPOX + HC and HC + HYPOX, compared with protocol control and the preceding single blood gas derangement. The decrease in effective renal plasma flow during combined hypoxemia and hypercapnic acidosis in Protocol I was accompanied by an increase in renal vascular resistance. Renal vascular resistance was unchanged from C of 28 ± 4 to 28 ± 3 dynes sec cm" 5 x 10 3 during HYPOX, but increased (P < 0.05) to 144 ± 45 dynes sec cm" 5 X 10 3 during HYPOX + HC in Protocol I. However, renal vascular resistance was unchanged from C of 23 ± 4 to 29 ± 3 X 10 3 and 54 ± 8 dynes sec cm" 5 x 10 3 during HC and HC -I-HYPOX, respectively, in Protocol II.
Urinary sodium excretion (Table 4) was unchanged during HYPOX + HC and HC + HYPOX in Protocols I and II, compared with the respective protocol controls. However, urinary sodium excretion was diminished (P < 0.05) during HYPOX + HC, compared with HYPOX in Protocol I. Although fractional sodium reabsorption was unchanged, filtered sodium load fell (P < 0.001) during HYPOX + HC and HC + HYPOX, compared with protocol control and the preceding single blood gas derangement.
Hematocrit was unchanged from control to the preceding single derangement or the combined blood gas derangement in Protocols I and II. However, a slight but significant (P < 0.05) decrease in hematocrit was observed in the post-control period, which was 4 ± 1% in Protocol I and 3 ± 0.8% in Protocol II. Abbreviations: HYPOX = acute hypoxemia, HC = acute hypercapnic acidosis, V E = minute ventilation, TC = time-control * Denotes significant difference from protocol control value, P < 0.05. j Denotes significant difference between BGD, and BGD2, P < 0 05.
Systemic Hemodynamic and Renal Effects of Acute Hypoxemia or Hypercapnic Acidosis Alone (Tables 3 and 4), Figs. 1-3)
Mean arterial pressure (Fig. 1) , heart rate, and cardiac output (Table 3 ) increased (P < 0.05) during HYPOX alone and HC alone (HC,). However, all systemic hemodynamic variables were unchanged during the normoxemic, normocapnic time-control except for a slight increase in heart rate in the postcontrol period.
Glomerular filtration rate (Fig. 2) , effective renal plasma flow (Fig. 3) , and renal vascular resistance were unchanged during HYPOX alone and HC alone, compared with protocol control. However, effective renal plasma flow decreased (P < 0.05) from HYPOX, to HYPOX 2 . Glomerular filtration rate and effective renal plasma flow were unchanged during the time-control.
Urinary sodium excretion (Table 4 ) increased (P < 0.05) during HYPOX alone and HC alone, but was unchanged during the time-control. Filtered sodium load (Table 4) was unchanged, but fractional sodium reabsorption fell (P < 0.01) during both HYPOX alone and HC alone during HYPOX, and HC,, respectively.
Hematocrit was unchanged from control to both hypoxemic periods in Protocol III and both hyper- Abbreviations: HYPOX = acute hypoxemia, HC = acute hypercapruc acidosis, HR = heart rate, CO = cardiac output, TPR = total peripheral resistance. * Denotes significant difference from protocol control value, P < 0.05. t Denotes significant difference between BGD, and BGD2, P < 0.05.
capnic periods in Protocol IV. However, a slight significant (P < 0.05) decrease in hematocrit of 3 ± 1 was observed from control to post-control periods in Protocol IV. Hematocrit decreased slightly but significantly (P < 0.05) during the time-control by 2 ± 0.5, 3 ± 0.4, and 2 ± 0.6% from control to TCi, TC 2 , and post-control, respectively.
Renin-Angioten8in Activation during Acute Blood Gas Derangements (Figs. 4 and 5)
Plasma renin activity (Fig. 4) increased 12-fold (P < 0.0005) during HYPOX + HC, and 10-fold (P < 0.005) during HC + HYPOX, compared with protocol control. Plasma renin activity increased 5-fold * Denotes significant difference from protocol control value, P < 0.05. f Denotes significant difference between BGD, and BGD^ P < 0.05. j Values in parentheses represent urinary sodium excretion, mEq 24/hr.
(P < 0.0005) during HYPOX alone (HYPOX 2 ) and during HC alone (HCi). Plasma rerun activity was unchanged in the normoxemic, normocapnic timecontrol except for a slight increase (P < 0.05) in the post-control period. The increase in plasma renin activity during HYPOX + HC, HC + HYPOX, and HYPOX 2 exceeded (P < 0.005) values observed in comparable periods during HC alone (HC 2 ) and time-control (TC 2 ). Plasma angiotensin II concentrations (Fig. 5 ) increased 9-fold (P < 0.005) during HYPOX + HC and 6-fold (P < 0.001) during HC + HYPOX, compared with the protocol control and the preceding single blood gas derangement periods. Plasma angiotensin II concentrations increased (P < 0.05) 4-fold during HYPOX alone (HYPOX 2 ) and 2-fold during HC alone (HCi), but were unchanged during the normoxemic, normocapnic time-control. Moreover, the change in plasma angiotensin II concentrations from preceding protocol control and single blood gas derangements to both combined hypoxemia and hypercapnia periods exceeded (P < 0.005) "observed values in comparable periods during HY-POX alone, HC alone, and the normoxemic, normocapnic time-control.
Systemic Hemodynamic and Renal Effects of Combined Acute Hypoxemia and Hypercapnic Acidosis with Angiotensin II Blockade (Tables 5 and 6)
The severity of combined hypoxemia and hypercapnic acidosis and the degree of hyperpnea were comparable between protocols with vehicle alone or [Sar',Ala 8 ]-AII infusion. Therefore the data were pooled. Pac>2 decreased (P < 0.05) from C of 81 ± 2 to 36 ± 3 mm Hg during combined HYPOX and HC, and was 81 ± 3 mm Hg during the post-control period. Paco 2 increased (P < 0.05) from C of 32 ± 1 to 51 ± 2 mm Hg during combined HYPOX and HC, and was associated with a fall (P < 0.05) in arterial pH from 7.40 ± 0.01 to 7.18 ± 0.01. Paco? and arterial pH were 28 ± 1 mm Hg and 7.40 ± 0.01, respectively in the post-control period. Minute ventilation increased (P < 0.05) from C of 4.1 ± 0.6 to 46.6 ± 5.1 liters/min during combined HYPOX and HC, and was 4.4 ± 1 . 0 liters/min in the post- control period. Thus, the severities of hypoxemia, hypercapnic acidosis, and hyperpnea in the angjotensin inhibition protocols were comparable to HY-POX + HC and HC + HYPOX periods in Protocols I and II. Mean arterial pressure, heart rate and cardiac output increased during combined HYPOX and HC with vehicle alone (Table 5 ). Mean arterial pressure increased but changes in heart rate and cardiac output were not statistically significant during combined HYPOX and HC with [Sar\Ala 8 ]-AII. The magnitude of the systemic pressor response during combined HYPOX and HC with [Sar^Ala^-AII appeared to be less than during combined HYPOX and HC with vehicle alone with a change of 13 ± 4 vs. 21 ± 4 mm Hg, respectively. However, these systemic pressor responses were not statistically different. In addition, total peripheral resistance fell during combined HYPOX and HC with vehicle alone, but was unchanged during combined HYPOX and HC with [Sar Renal vascular resistance was unchanged from C of 26 ± 3 to 89 ± 41 dynes sec arT 5 X 10 3 during combined HYPOX and HC with vehicle alone, and the increase from C of 29 ± 2 to 190 ± 82 dynes sec cm" 5 x 10 3 during combined HYPOX and HC with Abbreviations: combined HYPOX and HC = combined acute hypoxemia and hypercapnic acidosis, MAP = mean arterial pressure, HR = heart rate, CO = cardiac output, TPR = total peripheral resistance. * Denotes significant difference from protocol control values, P < 0.05. ]-AII approached but did not attain statistical significance (P = 0.067).
Urinary sodium excretion and fractional sodium reabsorption were unchanged during combined HY-POX and HC either with vehicle alone or with [Sar^Ala^-AII. Filtered sodium load was unchanged during combined HYPOX and HC with vehicle alone, but fell (P < 0.05) from C of 8032 ± 63 to 3407 to 842 /iEq/min during combined HYPOX and HC with [SarSAla^-AII, and was 6881 ± 1559 nEq/ min in the post-control period.
Only slight variations in hematocrit were noted. Hematocrit increased slightly (P < 0.05) by 1 ± 0.3% from control to combined HYPOX and HC with vehicle, and by 1 ± 0.3% from control to combined HYPOX and HC with [Sar\Ala 8 ]-AII. In addition, hematocrit decreased slightly (P < 0.05) by 1 ± 0.4% from the control to the post-control period following combined HYPOX and HC with vehicle alone.
Effects of [Sar\Ala 8 ]-AII Infusion during Normoxemia and Nonnocapnia (n = 4).
Control Pao 2 and Paco 2 of 83 ± 2 and 31 ± 1 mm Hg, respectively, were unchanged during the subsequent administration of [Sar , Ala 8 ]-AII or during the post-control periods. Arterial pH was also unchanged from control of 7.40 ± 0.01, and minute ventilation was unchanged from control of 2.8 ± 0.2 liters/min. Systemic (Table 5 ) and renal hemodynamic function (Table 6) 
Discussion
The present study clearly demonstrates that, in contrast to their separate effects, acute hypoxemia and hypercapnic acidosis act synergistically in unanesthetized dogs to diminish renal hemodynamic function and urinary sodium excretion concomitant with substantial activation of the renin-angiotensin system.
This study was undertaken because of conflicting results among previous laboratory investigations which assessed the effects of acute hypoxemia or hypercapnic acidosis on renal function. The main discrepancy between previous studies appears to be related to employment of barbiturates, positive pressure ventilation, and neuromuscular paralysis. Barbiturate anesthesia (Burger et al., 1976) and positive pressure ventilation (Bark et al., 1980 ) may themselves activate the renin-angiotensin system and/or diminish renal blood flow.
Thus, in contrast to previous investigations in anesthetized animals, unanesthetized animal and human studies have observed no impairment of renal function during acute hypoxemia (Toth, 1937; Lewis et al., 1942; Berger et al., 1949; Axelrod and Pitts, 1952; Ferguson and Smith, 1953; Ullman, 1961; Walker, 1982) and acute hypercapnic acidosis (Barbour et al., 1953; Anderson et al., 1980; Rose et al., 1982) . The systemic pressor and natriurenc responses during acute hypoxemia or hypercapnic acidosis in the present study are in agreement with these previous studies in unanesthetized animals.
The effects of combined hypoxemia and hypercapnic acidosis on renal function were evaluated because of previous clinical studies which observed that abnormalities in renal hemodynamic function were associated with hypercapnia and hypoxemia in contrast to hypoxemia alone (Aber et al., 1963; Farber et al., 1977) . Moreover, Weissman et al. (1976) observed increased renal vascular resistance in anesthetized cats during combined hypoxemia and hypercapnia (Pao? = 27 ± 1 mm Hg; Pacc>2 = 48 ± 1 mm Hg) despite a substantial increase in systemic arterial pressure. Recently, Koehler et al. (1980) observed a decrease in renal and mesenteric blood flow in conscious dogs during combined hypoxemia and hypercapnia (Pac>2 = 25 mm Hg, Paco? = 40 mm Hg). The present study clarifies the physiological significance of diminished renal blood flow during combined hypoxemia and hypercapnic acidosis, as evidenced by diminished glomerular filtration rate and urinary sodium excretion.
The major renal effect of the combined gas derangement in the present study appears to be upon hemodynamic function resulting in diminished delivery of water and electrolytes to the proximal tubule. Further support for this hypothesis is that impaired sodium excretion was associated with diminished filtered sodium load in the present study. However, the present study does not exclude a role for increased tubular reabsorption in view of the relatively high basal fractional reabsorption of sodium. If the study had been conducted under conditions of a lower fractional reabsorption of sodium, then increased tubular reabsorption may have been demonstrable, as well as diminished filtered sodium load.
Several possible mechanisms may have contributed to the diminished renal hemodynamic function during hypoxemia and hypercapnic acidosis, including the renin-angiotensin system, sympathetic nervous system, and vasopressin. The renin-angiotensin system was considered as a likely mediator of diminished renal hemodynamic function during combined acute hypoxemia and hypercapnic acidosis in view of the striking increase in circulating angiotensin II, and previous observations that peripheral angiotensin II infusion at 25 ng/kg per min resulted in diminished renal plasma flow and glomerular filtration rate (Healey et al., 1965) .
The increase in plasma renin activity (Liang and Gavras, 1978) and circulating angiotensin II (Zakheim et al., 1976) during acute hypoxemia has been observed in previous laboratory investigations in unanesthetized animals. In addition, the rise in plasma renin activity during acute hypercapnic acidosis in conscious dogs has been reported previously (Rose et al., 1982) . However, the synergjstic effect of combined hypoxemia and hypercapnic acidosis in renin-angiotensin activation has not been recognized previously.
In order to assess the role of the renin-angiotensin in diminished renal hemodynamic function, a competitive angiotensin antagonist was employed. Although possessing considerable affinity for and binding with angiotensin II receptors, the angiotensin II analog [Sar ]-AII has been previously documented in vitro using rabbit aortic strips, and in vivo in anesthetized rats (Pals et al., 1971 (Levens et al., 1983 ]-AII would have been identical to unchanged renal hemodynamic function during combined HYPOX and HC with vehicle. Diminished renal vascular responsiveness to angiotensin II during combined hypoxemia and hypercapnic acidosis is also not an attractive possibility. If the reninangiotensin system was substantially activated with minimal effect on the systemic or renal circulations because of diminished responsiveness, addition of an inhibitor of angiotensin II should have minimal effect.
The findings in the present study are most consistent with the hypothesis that angiotensin II maintained renal hemodynamic function during combined hypoxemia and hypercapnic acidosis. This effect could have been exerted through either systemic hemodynamic changes, or direct effects on the renal vasculature. The rise in mean arterial pressure during combined hypoxemia and hypercapnic acidosis with [Sar 1 , Ala ]-AII in the present study was comparable to vehicle alone. Because renal perfu-sion pressure was not measured in the present study, we cannot be absolutely sure that it was comparable between the angiotensin II inhibition and intact (vehicle alone) protocols. However, the similarity of the systemic pressor responses suggests that alteration of renal perfusion pressure was not responsible for diminished renal hemodynamic function with angiotensin II blockade. The alternate hypothesis is that angiotensin II maintained renal hemodynamic function through effects on the renal circulation. This possibility is supported by previous observations that angiotensin II is important in renal autoregulation during aortic constriction and diminished renal perfusion pressure in sodium-depleted anesthetized dogs (Hall et al., 1981) . These investigators observed that glomerular filtration rate was maintained during aortic constriction and decreased renal perfusion pressure in intact dogs. However, in the presence of angiotensin II blockade using the angiotensin I-converting enzyme inhibitor SQ14,225, comparable aortic constriction and reduction in renal perfusion resulted in diminished glomerular filtration rate and calculated efferent arteriolar resistance. Additional support for a selective effect of angiotensin II on the efferent renal arteriole can be found in a recent study assessing the effects of angiotensin II on isolated rabbit kidney afferent and efferent arterioles (Edwards, 1983) . Both types of vessels responded to norepinephrine, but only the efferent arteriole contracted with angiotensin II. These studies suggest angiotensin II may maintain glomerular filtration rate by acting preferentially on the efferent arteriole. Whereas renal blood flow was dissociated from the fall in glomerular filtration rate during aortic constriction with angiotensin II inhibition (Hall, et al., 1981) , effective renal plasma flow fell in parallel with glomerular filtration rate during hypoxemia and hypercapnic acidosis with angiotensin inhibition in the present study. Despite this dissimilarity, one explanation for the findings in the present study is that activation of the renin-angjotensin system maintains glomerular filtration rate during hypoxemia and hypercapnic acidosis through an effect on the efferent arteriole.
Other non-angiotensin factors may have mediated the renal vasoconstriction during hypoxemia and hypercapnic acidosis, including increased a-adrenergjc activity or increased circulating vasopressin. The observation that sinoaortic denervation abrogates the renal vasoconstriction during combined hypoxemia and hypercapnic acidosis suggests a role for the sympathetic nervous system (Koehler et al., 1980) . In addition, it is possible that angiotensin II inhibition in the present study may have enhanced the renal vasoconstriction from alternate systems including the a-adrenergic nervous system. Unfortunately, we have no direct information on these points, and future studies are needed to assess these possibilities.
Several possible explanations may be considered Circulation Research/Vo/. 53, No. 2, August 1983 for the disparity between the diminished renal hemodynamic function with combined hypercapnic acidosis with preceding hypoxemia or hypercapnic acidosis in Protocols I and II vs. unchanged renal hemodynamic function with the combined derangement without preceding derangement in Protocol VI. It certainly is possible that 80 minutes of hypoxemia or hypercapnic acidosis contributed to changes that led to renal vasoconstriction upon induction of the combined derangement. The mechanism by which renal vasoconstriction may have been enhanced by the preceding derangement is unclear, but it very likely does not involve the renin-angiotensin system, in view of the suggestion from the angiotensin inhibition protocols that angiotensin II maintains rather than diminishes renal hemodynamic function. We considered the possibility that the acetate/acetic acid vehicle used for the vasopressin antagonist in Protocol VI as part of another study may have abolished the renal vasoconstriction during hypoxemia or hypercapnic acidosis. This is unlikely because of the minute amount administered, and the evidence that the acidosis was not more severe during combined hypoxemia and hypercapnic acidosis than with [Sar ]-AII. In addition, administration of the acetic acid vehicle with the vasopressin pressor antagonist during a normoxemic normocapnic time-control (n = 4) resulted in no evidence for systemic or renal vasodilation, acidosis, or other untoward effects.
It is doubtful that the splenectomy performed in the present study contributed to changes in renal function. Changes in hematocrit during acute hypoxemia or hypercapnic acidosis were minimal, compared with the increase in hematocrit from 39 to 47 with hypercapnic acidosis previously reported in unsplenectomized dogs (Berns et al., 1979) . In addition, renal vasoconstriction has been previously observed during combined hypoxemia and hypercapnic acidosis in unsplenectomized conscious dogs (Koehler et al., 1980) . Taken together, the present investigation suggests that the renin-angiotensin system maintains renal hemodynamic function during combined hypoxemia and hypercapnic acidosis. However, the effects of the renin-angiotensin system on renal hemodynamic function during combined hypoxemia and hypercapnic acidosis can be evaluated definitively only by studies in which the angiotensin II inhibitor is infused selectively into the renal artery in doses that do not escape from the renal circulation with systemic effects.
In summary, neither acute hypoxemia nor acute hypercapnic acidosis alone results in renal dysfunction. In contrast, combined hypoxemia and hypercapnic acidosis acted synergjstically to diminish renal hemodynamic function and urinary sodium excretion despite an increase in systemic arterial pressure. In view of the effects of angiotensin II inhibition, this study suggests that the renin-angi-otensin system maintains renal hemodynamic function during combined hypoxemia and hypercapnic acidosis.
